HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.

Abstract
Spontaneously hypertensive rat (SHR) is a suitable model for studies of the complications of hypertension. It is known that activation of poly(ADP-ribose) polymerase enzyme (PARP) plays an important role in the development of postinfarction as well as long-term hypertension induced heart failure. In this study, we examined whether PARP-inhibitor (L-2286) treatment could prevent the development of hypertensive cardiopathy in SHRs. 6-week-old SHR animals were treated with L-2286 (SHR-L group) or placebo (SHR-C group) for 24 weeks. Wistar-Kyoto rats were used as aged-matched, normotensive controls (WKY group). Echocardiography was performed, brain-derived natriuretic peptide (BNP) activity and blood pressure were determined at the end of the study. We detected the extent of fibrotic areas. The amount of heat-shock proteins (Hsps) and the phosphorylation state of Akt-1(Ser473), glycogen synthase kinase (GSK)-3β(Ser9), forkhead transcription factor (FKHR)(Ser256), mitogen activated protein kinases (MAPKs), and protein kinase C (PKC) isoenzymes were monitored. The elevated blood pressure in SHRs was not influenced by PARP-inhibitor treatment. Systolic left ventricular function and BNP activity did not differ among the three groups. L-2286 treatment decreased the marked left ventricular (LV) hypertrophy which was developed in SHRs. Interstitial collagen deposition was also decreased by L-2286 treatment. The phosphorylation of extracellular signal-regulated kinase (ERK)1/2(Thr183-Tyr185), Akt-1(Ser473), GSK-3β(Ser9), FKHR(Ser256), and PKC ε(Ser729) and the level of Hsp90 were increased, while the activity of PKC α/βII(Thr638/641), ζ/λ(410/403) were mitigated by L-2286 administration. We could detect signs of LV hypertrophy without congestive heart failure in SHR groups. This alteration was prevented by PARP inhibition. Our results suggest that PARP-inhibitor treatment has protective effect already in the early stage of hypertensive myocardial remodeling.
AuthorsLaszlo Deres, Eva Bartha, Anita Palfi, Krisztian Eros, Adam Riba, Janos Lantos, Tamas Kalai, Kalman Hideg, Balazs Sumegi, Ferenc Gallyas, Kalman Toth, Robert Halmosi
JournalPloS one (PLoS One) Vol. 9 Issue 7 Pg. e102148 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25014216 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one
  • Forkhead Transcription Factors
  • HSP90 Heat-Shock Proteins
  • Isoenzymes
  • Nerve Tissue Proteins
  • Piperidines
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Quinazolines
  • Natriuretic Peptide, Brain
  • Foxo1 protein, rat
  • Poly(ADP-ribose) Polymerases
  • Akt1 protein, rat
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C
  • Extracellular Signal-Regulated MAP Kinases
  • Glycogen Synthase Kinase 3
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • Forkhead Transcription Factors (genetics, metabolism)
  • Gene Expression Regulation (drug effects)
  • Glycogen Synthase Kinase 3 (genetics, metabolism)
  • Glycogen Synthase Kinase 3 beta
  • HSP90 Heat-Shock Proteins (genetics, metabolism)
  • Heart Failure (etiology, genetics, physiopathology, prevention & control)
  • Hypertension (complications, drug therapy, genetics, physiopathology)
  • Hypertrophy, Left Ventricular (drug therapy, etiology, genetics, physiopathology)
  • Isoenzymes (genetics, metabolism)
  • Male
  • Natriuretic Peptide, Brain (genetics, metabolism)
  • Nerve Tissue Proteins (genetics, metabolism)
  • Phosphorylation
  • Piperidines (pharmacology)
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases (genetics, metabolism)
  • Protein Kinase C (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (genetics, metabolism)
  • Quinazolines (pharmacology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: